BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 22704562)

  • 1. Molecular profiling of an osseous metastasis in glioblastoma during checkpoint inhibition: potential mechanisms of immune escape.
    Mohme M; Maire CL; Schliffke S; Joosse SA; Alawi M; Matschke J; Schüller U; Dierlamm J; Martens T; Pantel K; Riethdorf S; Lamszus K; Westphal M
    Acta Neuropathol Commun; 2020 Mar; 8(1):28. PubMed ID: 32151286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteosclerosis Secondary to Metastatic Oligodendroglioma.
    Maloney PR; Yamaki VN; Kumar R; Johnson D; Hunt C; Jentoft ME; Clarke M
    Rare Tumors; 2017 Mar; 9(1):6837. PubMed ID: 28435646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Understanding of Circulating Tumor Cells - Potential Value in Malignancies of the Central Nervous System.
    Adamczyk LA; Williams H; Frankow A; Ellis HP; Haynes HR; Perks C; Holly JM; Kurian KM
    Front Neurol; 2015; 6():174. PubMed ID: 26322014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsies in patients with diffuse glioma.
    Best MG; Sol N; Zijl S; Reijneveld JC; Wesseling P; Wurdinger T
    Acta Neuropathol; 2015 Jun; 129(6):849-65. PubMed ID: 25720744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating glioma biomarkers.
    Kros JM; Mustafa DM; Dekker LJ; Sillevis Smitt PA; Luider TM; Zheng PP
    Neuro Oncol; 2015 Mar; 17(3):343-60. PubMed ID: 25253418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approach.
    Zupancic K; Blejec A; Herman A; Veber M; Verbovsek U; Korsic M; Knezevic M; Rozman P; Turnsek TL; Gruden K; Motaln H
    Radiol Oncol; 2014 Sep; 48(3):257-66. PubMed ID: 25177240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial astrocytoma with diffuse bone marrow metastasis: a case report and review of the literature.
    LoRusso PM; Tapazoglou E; Zarbo RJ; Cullis PA; Austin D; Al-Sarraf M
    J Neurooncol; 1988; 6(1):53-9. PubMed ID: 3294352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters.
    Gilheeney SW; Kieran MW
    Future Oncol; 2012 May; 8(5):549-58. PubMed ID: 22646770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diffuse bone marrow metastasis in cerebellar high-grade astrocytoma. A case report].
    Freitas MR; de Muzio SD; Pessoa RC; Stávale JN; Borges LR; Malheiros SM
    Rev Neurol; 2009 Mar 1-15; 48(5):242-4. PubMed ID: 19263392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.
    Jones DT; Mulholland SA; Pearson DM; Malley DS; Openshaw SW; Lambert SR; Liu L; Bäcklund LM; Ichimura K; Collins VP
    Acta Neuropathol; 2011 Jun; 121(6):753-61. PubMed ID: 21327941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A huge intraventricular congenital anaplastic astrocytoma: case report with histopathological and genetic consideration.
    Yamashita S; Ryu S; Miyata S; Uchinokura S; Yokogami K; Uehara H; Moriguchi S; Iwakiri T; Marutsuka K; Ikenoue M; Sawa D; Yamada N; Kodama Y; Takeshima H
    Brain Tumor Pathol; 2012 Apr; 29(2):107-12. PubMed ID: 22139530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival.
    Thon N; Eigenbrod S; Kreth S; Lutz J; Tonn JC; Kretzschmar H; Peraud A; Kreth FW
    Cancer; 2012 Jan; 118(2):452-60. PubMed ID: 21717448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal spread of an anaplastic astrocytoma (WHO grade III) and preservation of histopathological properties within metastases.
    Martens T; Matschke J; Müller C; Riethdorf S; Balabanov S; Westphal M; Heese O
    Clin Neurol Neurosurg; 2013 Mar; 115(3):323-8. PubMed ID: 22704562
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.